Welcome to our dedicated page for Rise Gold SEC filings (Ticker: RYES), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Rise Gold Corp. filings document the company’s Nevada corporate status, securities registrations and material-event disclosures tied to the Idaho-Maryland Mine. Recent 8-K reports cover material agreements for project development, court-schedule updates in litigation involving the mine’s operating rights, private placements of units and warrants, and compensatory issuances under the Long-Term Incentive Plan.
Registration and proxy filings describe common stock offering activity, smaller reporting company status, executive compensation, director elections, auditor ratification, equity incentive plans, and stockholder voting matters. The filing record also addresses ownership and capital-structure effects from warrants, stock options, deferred share units and other unregistered securities.
Rise Gold (RYES) reported an insider equity update. On 10/30/2025, the company’s Chief Financial Officer acquired 75,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring on 10/30/2030.
The filing also lists existing derivative holdings: stock options of 60,000 (exercisable 05/22/2025; expire 05/22/2030) and 60,000 (exercisable 03/25/2025; expire 03/25/2030) at $0.10, plus 60,976 warrants at $0.15 (exercisable 05/08/2025; expire 05/08/2028) held indirectly by Lazuli CPA Inc. Non‑derivative common stock beneficially owned is 121,952 shares, held indirectly by Lazuli CPA Inc.
Rise Gold Corp. (RYES) received a Schedule 13G disclosing that the Abdiel group reports beneficial ownership of 26,378,262 shares, representing 19.99% of the common stock.
The position comprises 14,791,440 common shares and 11,586,822 shares issuable upon exercise of warrants with an exercise price of $0.45 per share. A “Beneficial Ownership Blocker” limits exercises that would raise ownership above 19.99%, so an additional 3,204,618 warrant shares are excluded as not currently exercisable.
Percentage ownership is calculated using 120,370,467 shares outstanding as of October 27, 2025; this is a baseline figure, not the amount being acquired. The filing is made by Abdiel Capital Advisors, LP and affiliated entities, with certification that the securities are not held for the purpose of changing or influencing control.
Rise Gold Corp. (RYES) received an insider ownership filing noting Abdiel‑affiliated funds’ holdings. The reporting persons are marked as Director and 10% Owner.
The funds beneficially own 14,791,440 shares of common stock indirectly, held by Abdiel Investments LP (4,656,007) and Investment Group of Abdiel LP (10,135,433). They also hold warrants to purchase 14,791,440 common shares at $0.45 per share, first exercisable on 10/24/2025 and expiring on 10/24/2028.
The warrants are subject to a 19.99% Beneficial Ownership Blocker. As of this filing, warrants held by Abdiel Investments LP can be exercised for 3,647,267 shares, and those held by Investment Group of Abdiel LP can be exercised for 7,939,555 shares.
Rise Gold Corp. (RYES) filed its definitive proxy statement for the annual meeting on November 19, 2025, 10:00 a.m. (Vancouver time), at 1111 West Hastings, Vancouver. Stockholders will vote to: receive audited financials for FY ended July 31, 2025; set the board at five; elect directors; approve, on a non-binding basis, named executive officer compensation; re-appoint Davidson & Company LLP as auditor and authorize fees; and approve a new 10% rolling long-term incentive plan.
Ownership and governance highlights: 92,370,467 shares were outstanding as of the October 14, 2025 record date. Reported significant holders include Equinox Partners at 19.99% and Myrmikan Gold Fund at 14.8%. The audit committee (all independent) recommended inclusion of the FY2025 audited financial statements in the Form 10-K.
Compensation and performance: FY2025 CEO total compensation was $640,167; compensation actually paid to the PEO was $625,784. Average compensation actually paid to Non-PEO NEOs was $42,948. FY2025 net loss was $3,259 thousand.
Rise Gold Corp. filed its annual report, outlining financing, legal, and operational updates tied to its Idaho‑Maryland Gold Mine project. On October 24, 2025, the company raised $7,000,000 via up to 36,585,361 units at $0.25 per unit, each with a three‑year warrant exercisable at $0.45. Earlier, on May 8, 2025, it raised $3,000,000 through up to 36,585,361 units at $0.082 per unit with half‑warrants at $0.15 for three years.
Cash was $2,783,348 as of July 31, 2025, up from $243,669 a year earlier. The company reported a loss from operations of $3,260,358 for the year ended July 31, 2025. It contracted to sell 66 acres of industrial land for $4.3 million, with the 16‑acre portion closing on November 27, 2024 and a discounted payment of $702,000 received on January 14, 2025, and the 50‑acre portion closing on May 27, 2025 with interest at 5% on deferred balances and a repurchase option contingent on final approvals.
In its vested rights litigation, the Court rejected a County motion on August 8, 2025 and set briefs leading to oral arguments on January 9, 2026. The company also reported and repaid a $500,000 loan from Myrmikan and an amended Eridanus loan in May 2025. Shares outstanding were 120,370,467 as of October 27, 2025.
Rise Gold (RYES): Director and 10% owner Daniel Oliver reported buying 1,000,000 shares of common stock at $0.25 on 10/24/2025. Following the transaction, beneficial ownership was 14,663,191 shares held indirectly through Myrmikan Gold Fund, LLC and 1,210,653 shares held directly.
On the same date, the reporting persons also reported 1,000,000 new warrants with a $0.45 exercise price, held indirectly via Myrmikan Gold Fund, alongside previously reported options and warrants positions. A warrant standstill agreement dated 4/9/2024, as amended on 5/8/2025 and 10/24/2025, provides that the holder has agreed not to exercise specified warrants and may terminate the standstill with 61 days’ written notice; under this, the holder does not beneficially own the warrant underlying shares for Section 13(d) purposes. One prior warrant issuance was tied to a $500,000 secured loan to the issuer.
Rise Gold Corp. (RYES): Amendment No. 5 to Schedule 13D filed by Daniel Oliver Jr. and affiliates. The filing reports that Mr. Oliver beneficially owns 16,442,914 shares of common stock, representing 13.6% of the class, with 1,779,723 under sole voting and dispositive power and 14,663,191 under shared power through Myrmikan Capital, LLC.
On October 24, 2025, the Manager purchased 1,000,000 Units at $0.25 per Unit, each Unit consisting of one share and a warrant. Each warrant is exercisable at $0.45 for three years. Warrant standstill agreements currently prevent exercise, so shares underlying those warrants are not counted as beneficially owned for Section 13(d) purposes.
Myrmikan Capital, LLC reports beneficial ownership of 14,663,191 shares (12.2%). Myrmikan Gold Fund, LLC reports 0 shares beneficially owned, with a note that it lacks voting and dispositive power. Shares outstanding were 120,370,467 as of October 28, 2025.
Rise Gold (RYES): An insider group led by Equinox Partners Investment Management LLC and Sean M. Fieler reported open‑market purchases on 10/24/2025. Across affiliated vehicles, they acquired 5,600,000 shares at $0.25 per Unit, with each Unit consisting of one common share and one warrant.
The newly issued warrants are exercisable at $0.45 and expire on 10/24/2028. Post‑transaction, the filing lists updated beneficial holdings for each account, and also shows existing warrants with a $0.15 exercise price expiring on 05/08/2028. The warrants include a 19.99% Beneficial Ownership Limitation, which can be terminated by the holder with at least 61 days’ prior notice. The reporting persons disclaim beneficial ownership beyond their pecuniary interest.
Rise Gold Corp. (RYES) President and CEO Joseph Mullin reported buying 80,000 common shares at $0.25 on 10/24/2025, bringing his direct holdings to 701,095 shares.
He also acquired warrants for 80,000 shares with a $0.45 exercise price, expiring 10/24/2028. Additional holdings include indirect options via Mount Arvon Partners LLC covering 2,790,000 shares (to 05/22/2030), plus option grants for 812,410 (to 03/25/2030), 1,006,750 (to 09/19/2029), and 412,241 shares (to 05/01/2029). He also reports warrants of 121,951 (to 05/08/2028), 105,263 (to 04/09/2027), and 83,333 shares (to 11/07/2025).
Rise Gold Corp. (RYES) closed a non-brokered private placement. The Company raised US$7,000,000 through the sale of 28,000,000 units at US$0.25 per unit. Each unit included one common share and one warrant to purchase a share at US$0.45 until October 24, 2028.
Rise Gold also paid finder’s fees of US$1,500 and issued 6,000 finder’s warrants exercisable at US$0.45 until October 24, 2028. The securities were issued in reliance on Rule 903 of Regulation S for offshore transactions and on Section 4(a)(2) and Rule 506(b) of Regulation D for U.S. offers to accredited investors.